Snapshot · Russell 3000 · generated 2026-11-11 21:49 UTC

EWTX — Edgewise Therapeutics, Inc.

EXPENSIVE (MOS Model unreliable) · Quality 94/100

Value Score 30 days ago: 16 → today 13

EWTX - Edgewise Therapeutics, Inc.
Data generated 2026-11-11 21:49 UTC (nightly scan, universe: Russell 3000).
Price: 47.57 USD
Intrinsic value: 1.13 USD
Margin of safety: Model unreliable
Implied growth (reverse DCF): +60.0% (model assumes +6.5%)
Valuation: EXPENSIVE
Value Score: 13
Quality: 94/100
Moat score: 0 (erosion: none)
EXPENSIVE (MOS Model unreliable) - Quality 94/100
Source: StocksDeepDive - https://stocksdeepdive.com/s/EWTX
Factual information and general commentary only. StocksDeepDive publishes data, model outputs and described calculations from stated inputs. Nothing on this site takes your personal objectives, financial situation or needs into account, and nothing here is financial product advice or a recommendation to buy, hold or sell any security. Model outputs depend entirely on their stated inputs and assumptions. Consider seeking advice from a licensed adviser before acting. Data via Yahoo Finance, Google Trends, StockTwits and NewsAPI; figures may be delayed or revised.

Price

47.57

Intrinsic value

1.13

Margin of safety

Model unreliable

Implied growth (reverse DCF)

+60.0%

model assumes +6.5%

Value Score

Quality

Psychology

-55.4

Discovery

35.4

price/volume attention only

Moat score

erosion: none

Value Score: bottom 30% of Russell 3000 · Quality: top 2%

Open the interactive Deep Dive for EWTX →

Use this data programmatically

This page's numbers are also available as JSON at /api/v1/deep-dive/EWTX - see the API docs for the full read-only surface, including an MCP server for AI assistants.

Common questions

Is EWTX undervalued?

As of 2026-11-11, EWTX trades at 47.57 against a computed intrinsic value of 1.13 (-4109.7% margin of safety) - StocksDeepDive's valuation label for this is EXPENSIVE. This is a described calculation from public data, not a recommendation.

What is Edgewise Therapeutics, Inc.'s Value Score?

Edgewise Therapeutics, Inc.'s Value Score is 13 as of 2026-11-11 - it combines value, quality, crowd psychology and market attention into one number.